Diversified Financials Healthcare Sector

Mayne Pharma Group

Market Cap: AU$400.5m

A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

Inozyme Pharma

Market Cap: US$255.3m

A clinical-stage biopharmaceutical company, develops therapeutics for rare diseases that affect bone health and blood vessel function.

Vanda Pharmaceuticals

Market Cap: US$255.2m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Gossamer Bio

Market Cap: US$254.6m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

Healwell AI

Market Cap: CA$351.5m

A healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom.

Palvella Therapeutics

Market Cap: US$253.6m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.

Aquestive Therapeutics

Market Cap: US$253.3m

Operates as a pharmaceutical company in the United States and internationally.

Atea Pharmaceuticals

Market Cap: US$252.5m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

Rocket Pharmaceuticals

Market Cap: US$251.0m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Lexicon Pharmaceuticals

Market Cap: US$250.6m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.

AirSculpt Technologies

Market Cap: US$249.8m

Focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom.

ADC Therapeutics

Market Cap: US$247.9m

Provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

Prothena

Market Cap: US$246.5m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Neurogene

Market Cap: US$246.4m

A clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.

Animalcare Group

Market Cap: UK£182.1m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

Monte Rosa Therapeutics

Market Cap: US$245.4m

A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.

ZimVie

Market Cap: US$245.2m

Develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide.

Verano Holdings

Market Cap: CA$338.1m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Alumis

Market Cap: US$242.1m

A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

Tevogen Bio Holdings

Market Cap: US$240.9m

A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

Cerus

Market Cap: US$240.9m

Operates as a biomedical products company.

Creative Medical Technology Holdings

Market Cap: US$240.5m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

Tenax Therapeutics

Market Cap: US$240.1m

A clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.

SANUWAVE Health

Market Cap: US$239.1m

Operates as a medical device company in the United States and internationally.

Tristel

Market Cap: UK£176.5m

Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.

Tonix Pharmaceuticals Holding

Market Cap: US$238.0m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

Cartesian Therapeutics

Market Cap: US$237.7m

A clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

Jade Biosciences

Market Cap: US$237.6m

Operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.

MaxCyte

Market Cap: UK£176.0m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

Allogene Therapeutics

Market Cap: US$236.2m

A clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.

Silence Therapeutics

Market Cap: US$236.2m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Solid Biosciences

Market Cap: US$235.6m

Develops therapies for neuromuscular and cardiac diseases in the United States.

Amarin

Market Cap: US$235.2m

A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.

OptimizeRx

Market Cap: US$233.8m

Operates as a digital healthcare technology company.

Third Harmonic Bio

Market Cap: US$233.8m

A biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases.

Rezolute

Market Cap: US$231.9m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.